ai引导下低冠状动脉钙评分的1型糖尿病患者心脏计算机断层扫描

IF 6.3 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Peter Wohlfahrt, Michal Pazderník, Natália Marhefková, Robert Roland, Theodor Adla, James Earls, Martin Haluzík, Michal Dubský
{"title":"ai引导下低冠状动脉钙评分的1型糖尿病患者心脏计算机断层扫描","authors":"Peter Wohlfahrt, Michal Pazderník, Natália Marhefková, Robert Roland, Theodor Adla, James Earls, Martin Haluzík, Michal Dubský","doi":"10.1177/15209156251363492","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Objective:</i></b> Cardiovascular risk stratification based on traditional risk factors lacks precision at the individual level. While coronary artery calcium (CAC) scoring enhances risk prediction by detecting calcified atherosclerotic plaques, it may underestimate risk in individuals with noncalcified plaques-a pattern common in younger type 1 diabetes (T1D) patients. Understanding the prevalence of noncalcified atherosclerosis in T1D is crucial for developing more effective screening strategies. Therefore, this study aimed to assess the burden of clinically significant atherosclerosis in T1D patients with CAC <100 using artificial intelligence (AI)-guided quantitative coronary computed tomographic angiography (AI-QCT). <b><i>Methods:</i></b> This study enrolled T1D patients aged ≥30 years with disease duration ≥10 years and no manifest or symptomatic atherosclerotic cardiovascular disease (ASCVD). CAC and carotid ultrasound were assessed in all participants. AI-QCT was performed in patients with CAC 0 and at least one plaque in the carotid arteries or those with CAC 1-99. <b><i>Results:</i></b> Among the 167 participants (mean age 52 ± 10 years; 44% women; T1D duration 29 ± 11 years), 93 (56%) had CAC = 0, 46 (28%) had CAC 1-99, 8 (5%) had CAC 100-299, and 20 (12%) had CAC ≥300. AI-QCT was performed in a subset of 52 patients. Only 11 (21%) had no evidence of coronary artery disease. Significant coronary stenosis was identified in 17% of patients, and 30 (73%) presented with at least one high-risk plaque. Compared with CAC-based risk categories, AI-QCT reclassified 58% of patients, and 21% compared with the STENO1 risk categories. There was only fair agreement between AI-QCT and CAC (κ = 0.25), and a slight agreement between AI-QCT and STENO1 risk categories (κ = 0.02). <b><i>Conclusion:</i></b> AI-QCT may reveal subclinical atherosclerotic burden and high-risk features that remain undetected by traditional risk models or CAC. These findings challenge the assumption that a low CAC score equates to a low cardiovascular risk in T1D.</p>","PeriodicalId":11159,"journal":{"name":"Diabetes technology & therapeutics","volume":" ","pages":""},"PeriodicalIF":6.3000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AI-Guided Cardiac Computer Tomography in Type 1 Diabetes Patients with Low Coronary Artery Calcium Score.\",\"authors\":\"Peter Wohlfahrt, Michal Pazderník, Natália Marhefková, Robert Roland, Theodor Adla, James Earls, Martin Haluzík, Michal Dubský\",\"doi\":\"10.1177/15209156251363492\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Objective:</i></b> Cardiovascular risk stratification based on traditional risk factors lacks precision at the individual level. While coronary artery calcium (CAC) scoring enhances risk prediction by detecting calcified atherosclerotic plaques, it may underestimate risk in individuals with noncalcified plaques-a pattern common in younger type 1 diabetes (T1D) patients. Understanding the prevalence of noncalcified atherosclerosis in T1D is crucial for developing more effective screening strategies. Therefore, this study aimed to assess the burden of clinically significant atherosclerosis in T1D patients with CAC <100 using artificial intelligence (AI)-guided quantitative coronary computed tomographic angiography (AI-QCT). <b><i>Methods:</i></b> This study enrolled T1D patients aged ≥30 years with disease duration ≥10 years and no manifest or symptomatic atherosclerotic cardiovascular disease (ASCVD). CAC and carotid ultrasound were assessed in all participants. AI-QCT was performed in patients with CAC 0 and at least one plaque in the carotid arteries or those with CAC 1-99. <b><i>Results:</i></b> Among the 167 participants (mean age 52 ± 10 years; 44% women; T1D duration 29 ± 11 years), 93 (56%) had CAC = 0, 46 (28%) had CAC 1-99, 8 (5%) had CAC 100-299, and 20 (12%) had CAC ≥300. AI-QCT was performed in a subset of 52 patients. Only 11 (21%) had no evidence of coronary artery disease. Significant coronary stenosis was identified in 17% of patients, and 30 (73%) presented with at least one high-risk plaque. Compared with CAC-based risk categories, AI-QCT reclassified 58% of patients, and 21% compared with the STENO1 risk categories. There was only fair agreement between AI-QCT and CAC (κ = 0.25), and a slight agreement between AI-QCT and STENO1 risk categories (κ = 0.02). <b><i>Conclusion:</i></b> AI-QCT may reveal subclinical atherosclerotic burden and high-risk features that remain undetected by traditional risk models or CAC. These findings challenge the assumption that a low CAC score equates to a low cardiovascular risk in T1D.</p>\",\"PeriodicalId\":11159,\"journal\":{\"name\":\"Diabetes technology & therapeutics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":6.3000,\"publicationDate\":\"2025-07-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes technology & therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/15209156251363492\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes technology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15209156251363492","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:基于传统危险因素的心血管危险分层在个体水平上缺乏精确性。虽然冠状动脉钙化(CAC)评分通过检测钙化的动脉粥样硬化斑块增强了风险预测,但它可能低估了非钙化斑块个体的风险——这在年轻的1型糖尿病(T1D)患者中很常见。了解非钙化动脉粥样硬化在T1D中的患病率对于制定更有效的筛查策略至关重要。因此,本研究旨在评估伴有CAC的T1D患者的临床显著动脉粥样硬化负担。方法:本研究纳入年龄≥30岁、病程≥10年、无明显或症状性动脉粥样硬化性心血管疾病(ASCVD)的T1D患者。对所有参与者进行CAC和颈动脉超声检查。AI-QCT用于CAC为0且颈动脉中至少有一个斑块的患者或CAC为1-99的患者。结果:167名参与者(平均年龄52±10岁;44%的女性;T1D病程(29±11年),CAC = 0 93例(56%),CAC 1 ~ 99 46例(28%),CAC 100 ~ 299 8例(5%),CAC≥300 20例(12%)。AI-QCT在52例患者中进行。只有11人(21%)没有冠状动脉疾病的证据。在17%的患者中发现明显的冠状动脉狭窄,30例(73%)出现至少一个高危斑块。与基于cac的风险分类相比,AI-QCT对58%的患者进行了重新分类,与STENO1风险分类相比,这一比例为21%。AI-QCT与CAC之间仅存在一般的一致性(κ = 0.25), AI-QCT与STENO1风险类别之间存在轻微的一致性(κ = 0.02)。结论:AI-QCT可以揭示传统风险模型或CAC未发现的亚临床动脉粥样硬化负担和高危特征。这些发现挑战了低CAC评分等于低心血管风险的假设。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
AI-Guided Cardiac Computer Tomography in Type 1 Diabetes Patients with Low Coronary Artery Calcium Score.

Objective: Cardiovascular risk stratification based on traditional risk factors lacks precision at the individual level. While coronary artery calcium (CAC) scoring enhances risk prediction by detecting calcified atherosclerotic plaques, it may underestimate risk in individuals with noncalcified plaques-a pattern common in younger type 1 diabetes (T1D) patients. Understanding the prevalence of noncalcified atherosclerosis in T1D is crucial for developing more effective screening strategies. Therefore, this study aimed to assess the burden of clinically significant atherosclerosis in T1D patients with CAC <100 using artificial intelligence (AI)-guided quantitative coronary computed tomographic angiography (AI-QCT). Methods: This study enrolled T1D patients aged ≥30 years with disease duration ≥10 years and no manifest or symptomatic atherosclerotic cardiovascular disease (ASCVD). CAC and carotid ultrasound were assessed in all participants. AI-QCT was performed in patients with CAC 0 and at least one plaque in the carotid arteries or those with CAC 1-99. Results: Among the 167 participants (mean age 52 ± 10 years; 44% women; T1D duration 29 ± 11 years), 93 (56%) had CAC = 0, 46 (28%) had CAC 1-99, 8 (5%) had CAC 100-299, and 20 (12%) had CAC ≥300. AI-QCT was performed in a subset of 52 patients. Only 11 (21%) had no evidence of coronary artery disease. Significant coronary stenosis was identified in 17% of patients, and 30 (73%) presented with at least one high-risk plaque. Compared with CAC-based risk categories, AI-QCT reclassified 58% of patients, and 21% compared with the STENO1 risk categories. There was only fair agreement between AI-QCT and CAC (κ = 0.25), and a slight agreement between AI-QCT and STENO1 risk categories (κ = 0.02). Conclusion: AI-QCT may reveal subclinical atherosclerotic burden and high-risk features that remain undetected by traditional risk models or CAC. These findings challenge the assumption that a low CAC score equates to a low cardiovascular risk in T1D.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes technology & therapeutics
Diabetes technology & therapeutics 医学-内分泌学与代谢
CiteScore
10.60
自引率
14.80%
发文量
145
审稿时长
3-8 weeks
期刊介绍: Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信